Hepatocellular carcinoma in a noncirrhotic liver after long-term use of danazol for hereditary angioedema

Case Reports in Oncology

Volumn 7, Issue 3, 2014, Pages 825-827

  Rahal, Soraya ^a   Gilabert, Marine ^a   Ries, Pauline ^a   Oziel Taieb, Sandrine ^a   Dermeche, Slimane ^a   Raoul, Jean Luc ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Danazol; Drug induced cancer; Healthy liver; Hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; DANAZOL; GEMCITABINE; OXALIPLATIN; SORAFENIB;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SIZE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM CARE; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 84927131195     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000370106     Document Type: Article

References (7)

1. Farrel GC, Joshua DE, Uren RF, Baird PJ, Perkins KW, Kronenberg H: Androgen-induced hepatoma. Lancet 1975;305:430-432.
2. Velazquez I, Alter BP: Androgens and liver tumors : Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004;77:257-267.
3. Bork K, Pitton M, Harten P, Koch P: Hepatocellular adenomas in patients taking danazol for hereditary angiooedema. Lancet 1999;353:1066-1067.
4. Helsing P, Nielsen EW: Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema. Acta Derm Venereol 2006;86:272-273.
5. Confavreux C, Seve P, Broussolle C, Renaudier P, Ducerf C: Danazol-induced hepatocellular carcinoma. QJM 2003;96:317-318.
6. Zaanan A, Williet N, Hebbar M, Dabakuyo TS, Fartoux L, Mansourbakht T, et al: Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study. J Hepatol 2013;58:81-88.
7. Kalaria S, Craig T: Assessment of hereditary angioedema treatment risks. Allergy Asthma Proc 2013;34:519-522.